Top Markets
Coin of the day
HAVN Life Sciences Inc. HAVN Life Sciences Inc.

HAVN Life Sciences Inc.

HAVN
Rank in Stocks #38702
HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and... HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and creation of psychotropic compounds sourced from flora and fungi. The company's expertise includes devising standardized and quality-assured extraction techniques for psychoactive substances, particularly from Psilocybe mushrooms, to isolate key compounds such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health remedies using non-regulated ingredients. This Canadian company, founded in 2020, is headquartered in Richmond.
Share Price
$0.02201811
Last synced: 2024-07-23
Market Cap
$847.02K
Change (1 day)
-0.22%
Change (1 year)
0.00%
Country
CA
Trade HAVN Life Sciences Inc. (HAVN)

Category

EPS for HAVN Life Sciences Inc. (HAVN)
EPS as of 2026 TTM: 0
According to HAVN Life Sciences Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for HAVN Life Sciences Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE